LeonaBio(退市)

$Athira(ATHA)$ $Safe Pro Group(SPAI)$ 今晚盘前两只都有小利润

$Athira(ATHA)$ 利好 -获得三期乳腺癌药物权益正在进行的ELAINE-3三期临床试验已完成超过50%的招募，预计将在2027年中期获得数据。

$Athira(ATHA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001636587-25-000065  Act: 34  Size: 12 KB 网页链接

$Athira(ATHA)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-331145  Act: 34  Size: 27 KB 网页链接

$Athira(ATHA)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-328818  Act: 34  Size: 15 KB 网页链接

$Athira(ATHA)$ 8-K Current report, items 1.01, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-323692  Act: 34  Size: 27 MB 网页链接

$Athira(ATHA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001373604-25-000127  Act: 34  Size: 7 KB 网页链接

$Athira(ATHA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001957912-25-000008  Act: 34  Size: 17 KB 网页链接

$LeonaBio(ATHA)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-26-016629  Act: 33  Size: 1 MB 网页链接

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001794629-25-000003  Size: 6 KB 网页链接

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001822499-25-000005  Size: 6 KB 网页链接

$Athira(ATHA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001636587-26-000001  Act: 34  Size: 12 KB 网页链接

$Athira(ATHA)$ Baselake Partners, LP、Baselake Management, LLC 以及 David Paolella 已联合向美国证券交易委员会（SEC）提交了13G表格，报告其持有 Athira Pharma, Inc. 的197,481股普通股，占已发行股份的5.0%。文件显示这些股份由Baselake Partners, LP持有，其中Baselake Management, LLC担...

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001822499-26-000002  Size: 12 KB 网页链接

$LeonaBio(ATHA)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-26-016699  Act: 33  Size: 1 MB 网页链接

$LeonaBio(ATHA)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-26-037767  Act: 34  Size: 2 MB 网页链接

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001794629-26-000002  Size: 10 KB 网页链接

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001604834-26-000002  Size: 13 KB 网页链接

$Athira(ATHA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002037968-26-000002  Size: 12 KB 网页链接

$Athira(ATHA)$ 本文件涉及Athira Pharma, Inc.，报告截至2025年11月18日的实益所有权信息。百分比基于9,604,313股流通普通股计算。ACORN BIOVENTURES, L.P.持有210,730股，占2.2%的所有权。作为普通合伙人，ACORN CAPITAL ADVISORS GP, LLC可能被视为实益拥有这些股份。ACORN BIOVENTURES 2, L.P....